8-K: Genworth Financial Reports Mixed Q2 2025 Results Amid Strategic Progress and Share Buybacks

Genworth Financial announced solid second quarter results, driven by strong Enact performance and CareScout expansion, despite a decline in net income and continued losses in its long-term care segment.

Summary

• Net income for the quarter ended June 30, 2025, was $51 million, or $0.12 per diluted share, down from $76 million ($0.17 per diluted share) in Q2 2024.
• Adjusted operating income was $68 million, or $0.16 per diluted share, an increase from $51 million in Q1 2025 but a decrease from $125 million in Q2 2024.
• Enact, the mortgage insurance provider, reported adjusted operating income of $141 million and distributed $94 million in capital returns to Genworth.
• The U.S. life insurance companies' estimated Risk-Based Capital (RBC) ratio was 304%, reflecting strong statutory earnings offsetting higher required capital due to limited partnership portfolio growth.
• Genworth's holding company cash and liquid assets stood at $248 million at quarter-end, up from $211 million in Q1 2025 but down from $281 million in Q2 2024.
• The company repurchased $30 million in shares during the quarter at an average price of $7.01 per share, bringing total repurchases to $620 million since program inception.
• The Long-Term Care (LTC) multi-year rate action plan achieved $41 million of gross incremental premium approvals in the quarter, contributing to an estimated $31.6 billion net present value since 2012.
• CareScout, Genworth's long-term growth platform, expanded its Quality Network to consumers in all 50 states and launched 'Care Plans,' a new fee-based service.
• A favorable ruling for AXA in the UK Payment Protection Insurance Case means Genworth will share in recovered funds.
• The Long-Term Care Insurance segment reported an adjusted operating loss of $37 million, worsening from $30 million in Q1 2025 and $29 million in Q2 2024, primarily due to unfavorable actual variances from expected experience (lower terminations, higher benefit utilization).

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While net income and adjusted operating income are down year-over-year, the company highlights strategic progress in CareScout, strong capital returns from Enact, and a favorable legal ruling. The persistent losses in the legacy LTC segment are a known challenge, and the overall tone emphasizes execution on strategic priorities and shareholder returns.

Positives

• Enact delivered strong performance, contributing $141 million in adjusted operating income and distributing $94 million in capital returns to Genworth.
• CareScout expanded its Quality Network to consumers in all 50 states and launched 'Care Plans,' a new fee-based service, indicating progress in the long-term growth platform.
• Genworth repurchased $30 million of shares in the quarter at an average price of $7.01 per share, demonstrating continued capital return to shareholders.
• The company has achieved approximately $31.6 billion in estimated net present value since 2012 from in-force rate actions (IFAs) in its Long-Term Care business, with $41 million in gross incremental premium approvals in Q2 2025.
• A favorable ruling for AXA in the UK Payment Protection Insurance Case means Genworth will share in recovered funds, providing a potential financial upside.
• Adjusted operating income increased to $68 million in Q2 2025 from $51 million in Q1 2025.
• Net investment income increased to $634 million in Q2 2025 from $584 million in Q1 2025, driven by higher income from limited partnerships.
• Enact's primary new insurance written (NIW) was up 35% from the prior quarter, indicating strong new business volume.
• Enact's loss ratio improved to 10% in Q2 2025 from 12% in Q1 2025.
• Enact's equity increased to $4,244 million in Q2 2025 from $4,159 million in Q1 2025.
• U.S. life insurance companies' statutory pre-tax income significantly improved to $81 million in Q2 2025 from a loss of $1 million in Q1 2025.

Negatives

• Net income decreased to $51 million in Q2 2025 from $76 million in Q2 2024.
• Adjusted operating income decreased to $68 million in Q2 2025 from $125 million in Q2 2024.
• The Long-Term Care Insurance segment's adjusted operating loss worsened to $37 million in Q2 2025 from $29 million in Q2 2024, primarily due to unfavorable actual variances from expected experience (lower terminations and higher benefit utilization).
• Net investment losses, net of taxes, were $22 million in Q2 2025, compared to net investment gains of $21 million in Q1 2025.
• Enact's adjusted operating income of $141 million in Q2 2025 was lower than $165 million in Q2 2024.
• The U.S. life insurance companies' estimated RBC ratio decreased to 304% in Q2 2025 from 319% in Q2 2024.
• Genworth's holding company cash and liquid assets decreased to $248 million at quarter-end from $281 million in Q2 2024.
• The Corporate and Other segment's adjusted operating loss worsened to $29 million in Q2 2025 from $10 million in Q2 2024, primarily due to the timing of favorable tax-related items in the prior year.
• The Long-Term Care Insurance segment's statutory pre-tax income was a loss of $26 million in Q2 2025, significantly lower than $106 million in Q2 2024, as the Choice II legal settlement is complete.

Risks

• Inability to successfully launch new lines of business, including long-term care insurance and other products and services through CareScout.
• Failure to maintain the self-sustainability of legacy U.S. life insurance subsidiaries, potentially due to inability to achieve desired levels of in-force rate actions or delays in premium rate increases and benefit reductions.
• Inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections, and/or models, which could result in inadequate reserves or other adverse results.
• Impact on holding company liquidity caused by an inability to receive dividends or other capital returns from Enact Holdings, and limited sources of capital and financing.
• Adverse changes to the structure or requirements of Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), or the U.S. mortgage insurance market.
• An increase in the number of loans insured through federal government mortgage insurance programs, such as those offered by the Federal Housing Administration.
• Inability of Enact Holdings and/or its U.S. mortgage insurance subsidiaries to continue to meet the requirements mandated by PMIERs or minimum statutory capital requirements.
• Changes in economic, market, and political conditions, labor shortages, fluctuating interest rates, a recession, or a decline in home prices.
• An increase in the cost of care impacting the company's long-term care insurance business.
• Changes in government or monetary policies, including U.S. federal tax laws (e.g., the 'One Big Beautiful Bill Act' signed July 4, 2025), tax rates, or interest rates.
• Downgrades in financial strength and credit ratings and potential adverse impacts to liquidity.
• Litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties.
• The inability to retain, attract, and motivate qualified employees or senior management.
• The impact from deficiencies in the company's disclosure controls and procedures or internal control over financial reporting.
• The occurrence of natural or man-made disasters, including geopolitical tensions and war (e.g., Russian invasion of Ukraine, Israel-Hamas conflict), a public health emergency, or climate change.
• The inability to effectively manage information technology systems (including artificial intelligence), cyber incidents, or other failures, disruptions, or security breaches.
• The lack of availability, affordability, or adequacy of reinsurance to protect the company against losses.
• A decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations.
• Unanticipated claims against Enact Holdings' delegated underwriting and loss mitigation programs.
• The impact of medical advances such as genetic research and diagnostic imaging, and emerging new technology, including artificial intelligence and related legislation.

Future Outlook

The company remains focused on building its CareScout growth platform, maintaining the self-sustainability of its legacy insurance companies, and returning capital to shareholders in the second half of the year. Forward-looking statements indicate potential future share repurchases, debt repurchases, and investments in new businesses, including through CareScout. The company expects quarterly adverse variances between actual and expected experience could persist, resulting in future remeasurement losses in its long-term care insurance business.

Management Comments

• "Genworth delivered solid second quarter results as we continued to execute against our strategic priorities."
• "Enact continued its strong performance, driving meaningful capital returns that fueled our share repurchase program."
• "CareScout, our long-term growth platform, reached exciting milestones including the expansion of the CareScout Quality Network directly to consumers in all 50 states and the launch of Care Plans to help more families navigate aging with clarity and confidence."
• "As we navigate the second half of the year, we remain focused on building our growth platform while maintaining the self-sustainability of our legacy insurance companies and returning capital to shareholders."

Industry Context

The results reflect ongoing trends in the insurance industry, with strong performance in mortgage insurance (Enact) benefiting from market conditions, while the long-term care insurance segment continues to face challenges related to claims experience and the need for in-force rate actions. The expansion of CareScout into direct-to-consumer services aligns with a broader industry shift towards integrated care solutions and aging-in-place support, addressing the growing needs of an aging population.

Comparison to Industry Standards

• Enact's PMIERs sufficiency ratio of 165% ($1,961 million above requirements) indicates strong capital adequacy within the mortgage insurance sector, comparable to leading U.S. mortgage insurers like MGIC Investment Corporation (MTG) or Radian Group Inc. (RDN), which also maintain robust capital positions relative to regulatory requirements.
• The Long-Term Care (LTC) segment's continued operating losses and liability remeasurement losses are consistent with the broader challenges faced by the LTC insurance industry, where many legacy blocks of business across companies like Unum Group (UNM) or Manulife Financial Corporation (MFC) have experienced unfavorable claims trends and require ongoing premium increases and reserve adjustments.
• The U.S. life insurance companies' RBC ratio of 304% is within a healthy range for the life insurance industry, generally above the 200-250% company action level, indicating sufficient capital to absorb potential losses, similar to other diversified insurers like Prudential Financial, Inc. (PRU) or MetLife, Inc. (MET).

Legal Proceedings

• Favorable ruling for AXA in the UK Payment Protection Insurance Case, with Genworth to share in recovered funds.
• Loss from discontinued operations primarily relates to legal costs related to litigation involving the company's former lifestyle protection insurance business.
• The Long-Term Care segment's statutory results were lower than the prior year as the Choice II legal settlement is complete.

Stakeholder Impact

• Shareholders benefit from the ongoing share repurchase program ($30 million in Q2 2025) and potential recovery from the AXA litigation.
• Customers of CareScout benefit from the expansion of the CareScout Quality Network to all 50 states and the launch of new 'Care Plans' services, enhancing support for long-term care needs.
• Long-Term Care policyholders are impacted by the continued implementation of in-force rate actions, which involve premium increases and benefit reductions.

Next Steps

• Genworth Financial will conduct a conference call on July 31, 2025, at 9:00 a.m. (ET) to discuss its second quarter results.
• Enact Holdings, Inc. will hold a conference call on July 31, 2025, at 8:00 a.m. (ET) to discuss its second quarter results.
• The company remains focused on building its CareScout growth platform, maintaining the self-sustainability of its legacy insurance companies, and returning capital to shareholders in the second half of the year.

Key Dates

Recommendation

The filing presents a mixed financial picture. While Enact continues to be a strong performer, generating significant capital returns, and the CareScout platform shows promising strategic growth, the legacy Long-Term Care segment continues to incur operating losses and liability remeasurement losses. The overall net income and adjusted operating income are down year-over-year, but the company is actively returning capital to shareholders through buybacks. The favorable AXA ruling is a positive, but the completion of the Choice II legal settlement impacts LTC statutory results negatively. Given the ongoing efforts to manage legacy businesses while investing in growth, a 'hold' recommendation is appropriate, as the company navigates these transitions, and the long-term outlook depends on the successful execution of its strategic priorities and effective management of its legacy liabilities.

Keywords

Financial Services, Insurance, Mortgage Insurance, Long-Term Care Insurance, Life Insurance, Annuities, CareScout, Share Repurchase, Capital Allocation, SEC Filing, Earnings Report, Financial Results, Risk-Based Capital, PMIERs, In-Force Rate Actions, AXA Litigation